Immobilized cellulose nanospheres in lateral flow immunoassay enable rapid nucleocapsid antigen-based diagnosis of SARS-CoV-2 from salivary samples

01 November 2021, Version 1
This content is a preprint and has not undergone peer review at the time of posting.


Rapid and efficient diagnostic systems are essential in controlling the spread of viral pathogens and efficient patient management. The available technologies for low-cost viral antigen testing have several limitations, including lack of accuracy and sensitivity. Here, we develop sensitive antigen tests based on recently introduced, oppositely charged cellulose II nanoparticles (NPan and NPcat) that are effective in controlling surface protein interactions. Passivation against non-specific adsorption and augmented immobilization of sensing antibodies are achieved by adjusting the electrostatic charge of the nanoparticles. The interactions affecting the performance of the system are investigated by microgravimetry and confocal imaging. We further demonstrate SARS-CoV-2 nucleocapsid rapid sensing by saliva-wicking channels stencil-printed on flexible paper supports. Therein, NPcat inkjet printed on the channels elicit distinctive optical signals, visible after only a few minutes, allowing faster diagnosis compared to current microfluidic devices designed for saliva sampling.


Protein interactions
Paper-based diagnostics
coronavirus antigen test


Comments are not moderated before they are posted, but they can be removed by the site moderators if they are found to be in contravention of our Commenting Policy [opens in a new tab] - please read this policy before you post. Comments should be used for scholarly discussion of the content in question. You can find more information about how to use the commenting feature here [opens in a new tab] .
This site is protected by reCAPTCHA and the Google Privacy Policy [opens in a new tab] and Terms of Service [opens in a new tab] apply.